International Cannabis Weekly: 313

SWITZERLAND LAUNCHES ITS SECOND CANNABIS PILOT TRIAL IN ZURICH

The city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trials “ZüriCan”. These trials represent a further development in the legalisation and regulation of cannabis in Switzerland.

READ MORE  »

PHARMA INDUSTRY INTEREST GROWS AS M&A ACTIVITY INCREASES

READ MORE »

MICHIGAN ON TRACK TO BECOME SECOND LARGEST CANNABIS MARKET IN THE US

READ MORE »

• German cannabis group SynBiotic announces new €3 million investment, new acquisition and new CEO.
• Cannabis Poland announces second quarter financial 2023 results, reporting 17% loss.
• UK sees the second highest number of clinical trials carried out on cannabinoids in last decade, according to new report. 
• New study in Greece finds medical cannabis improves job performance as well as having a myriad of other benefits.
• Ukraine Health Ministry calls for relaxation of cannabis laws to facilitate medical use.
• Pharma C receives £30k fine for Aquis rule breaches, and Akanda pays off Halo loans with stock.

READ WEEKLY STOCK REPORT »

• New York’s rocky road to the rollout of its adult-use cannabis market faces another set back as injunction granted.
• Ohio confirms it will vote on cannabis legalisation for adult-use purposes in November.
• Alabama’s medical cannabis regulators face another lawsuit after rescinding a licence it had issued to Verano.
• Nevada’s cannabis industry takes another step forward as four significant cannabis regulation bills are signed into law.
• The City of Lubbock, Texas, launches initiative in a bid to decriminalise low-level cannabis possession.
• New research shows 14 states and cities have now cut taxes to help support cannabis businesses.

FIND OUT MORE »

• Tilray confirms acquisition of drinks brand Truss Beverage Co. from Molson Coors Canada.
• New report from Health Canada reveals high fees on cannabis businesses are preventing profits in the industry.
• Toronto’s Organigram announces relaunch of one of Canada’s best known cannabis brands, Trailblazer.
• Canopy Growth confirms sale of its facility in Ontario, back to its original owner Hershey Canada – for C$53 million.
• Vancouver’s AgriCann announces strategic partnership agreement with Klonetics Plant Science Inc.
• Melodiol Global Health’s subsidiary Mernova Medical on track to significantly increase its quarter-on-quarter growth.

BUY TICKETS »

• Anvisa, Brazil’s Health Regulatory Agency, clarifies its strict regulations on the promotion of cannabis products.
• Mexican government continues to inspect and monitor non-compliant prohibited products.
• California’s Athena Cannabis announces addition of new Market Director and Latam Consultant.
• Cannabis against HIV: Bolivia tests the medicinal benefits in people living with the virus.

• Australian study expected to be the world’s largest on the health economic impact of medical cannabis.
• Thailand’s cannabis regulation is back on the agenda as the number of cannabis outlets continues to rise.
• Cannabis use is a growing medicinal trend in NZ rugby, and a former All Black believes it should be embraced.
• Releaf announces International College of Cannabinoid Medicine (ICCM) workshop dates for Australia and the UK.

• Morocco taking effective measures to streamline cannabis cultivation for the global stage.
• Chicago’s Seed and Beyond partners with Bpure, a leading medical cannabis grower and exporter in Africa.